I'm hoping someone could explain the need for the level of staff that is generating an expense of over $ 5.1m YTD. From what has been produced so far that's way too high and not sustainable moving forward. Cash burn for me is a serious impediment to the success of this company.
- Forums
- ASX - By Stock
- TTT
- Ann: Review of Operations Q3 FY2022
Ann: Review of Operations Q3 FY2022, page-6
Featured News
Add TTT (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.020(9.52%) |
Mkt cap ! $226.2M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.0¢ | $867.1K | 4.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 843707 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 84457 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 843707 | 0.190 |
14 | 705994 | 0.185 |
12 | 612927 | 0.180 |
5 | 86714 | 0.175 |
4 | 212128 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 84457 | 13 |
0.200 | 417734 | 6 |
0.210 | 9767 | 2 |
0.215 | 26600 | 2 |
0.220 | 18960 | 2 |
Last trade - 14.19pm 15/11/2024 (20 minute delay) ? |
Featured News
TTT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online